Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Idris, I. M., Burnett, A. L. & DeBaun, M. R. Epidemiology and treatment of priapism in sickle cell disease. Hematol. Am. Soc. Hematol. Educ. Program 2022, 450–458 (2022).
2. Bivalacqua, T. J. et al. Acute ischemic priapism: an AUA/SMSNA guideline. J. Urol. 206, 1114–1121 (2021).
3. Alkindi, S., Almufargi, S. S. & Pathare, A. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients. Exp. Biol. Med. 245, 79–83 (2020).
4. Figueiredo, C. V. B. et al. Priapism in sickle cell disease: associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers. PLoS ONE 16, e0246067 (2021).
5. Zakaria, O. et al. Clinical and laboratory predictors of painful vaso-occlusive crisis among sickle cell disease patients: a single-center study in Saudi Arabia. Cureus 13, e14980 (2021).